Advertisement
Singapore markets close in 1 hour 36 minutes
  • Straits Times Index

    3,279.25
    -8.50 (-0.26%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,654.07
    +369.53 (+2.14%)
     
  • FTSE 100

    8,127.23
    +48.37 (+0.60%)
     
  • Bitcoin USD

    64,394.82
    +117.50 (+0.18%)
     
  • CMC Crypto 200

    1,388.32
    -8.21 (-0.59%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,350.50
    +8.00 (+0.34%)
     
  • Crude Oil

    84.19
    +0.62 (+0.74%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,574.39
    +5.14 (+0.33%)
     
  • Jakarta Composite Index

    7,104.03
    -51.26 (-0.72%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Can This 1 Thing Hurt Vaxart?

Can This 1 Thing Hurt Vaxart?

Vaxart (NASDAQ: VXRT) has been involved in the coronavirus vaccine race since the beginning. All of this means there is one big problem for Vaxart right now. Vaxart's biggest problem is the time it's taking the company to bring its candidate through development to commercialization.